Stock data
Edesa Biotech, Inc. (EDSA)
Edesa Biotech, Inc. (EDSA) reported net income of -US$7.19M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-09-30
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$7.91M | -US$7.19M | — |
| 2024 | — | — | -US$7.01M | -US$6.17M | — |
| 2023 | — | — | -US$9.22M | -US$8.37M | — |
| 2022 | — | — | -US$18.37M | -US$17.55M | — |
| 2021 | US$0.00M | — | -US$23.68M | -US$13.34M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$5.41M | — |
| 2026-03-31 | — | -US$4.22M | — |
| 2025-12-31 | — | -US$2.25M | — |
| 2025-09-30 | — | -US$2.23M | — |
| 2025-06-30 | — | -US$1.75M | — |
| 2025-03-31 | — | -US$1.59M | — |
| 2024-12-31 | — | -US$1.62M | — |
| 2024-09-30 | — | -US$0.96M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.